By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



99 Hayden Avenue
Suite 390
Lexington  Massachusetts  02421  U.S.A.
Phone: 781-357-2333 Fax: 781-357-2399



Company News
Pulmatrix Issued New Composition Of Matter Patent Covering iSPERSE Technology 9/2/2015 6:54:35 AM
Vertex (VRTX)'s Success Spurs Startups Corbus and Pulmatrix to Enter Cystic Fibrosis Market 8/18/2015 6:21:45 AM
Pulmatrix Reports 2nd Quarter Results; Provides Update On Business & Development Pipeline 8/14/2015 7:22:07 AM
Pulmatrix Presentation Now Available For On-Demand Viewing 8/12/2015 11:16:40 AM
Pulmatrix To Webcast Investor Presentation And Provide Update On Pipeline Of Inhaled Therapeutics August 6th 7/30/2015 10:39:22 AM
Pulmatrix Issued Patents Covering iSPERSE Technology For Treatment Of Patients With Inhaled Dry Powders 7/23/2015 8:58:03 AM
Pulmatrix Appoints William Duke, Jr., As Chief Financial Officer 6/25/2015 7:16:45 AM
Pulmatrix Announces Appointment Of Michael Higgins To Board Of Directors 6/18/2015 7:32:53 AM
Pulmatrix Raises $10 Million Private Placement; To Begin Trading On NASDAQ Under "PULM" 6/16/2015 9:10:49 AM
Pulmatrix Announces First Inhaled Anti-fungal Therapy For Cystic Fibrosis 6/16/2015 8:18:25 AM